Skip to main content
. 2014 Sep 8;15(5):207–215. doi: 10.1120/jacmp.v15i5.4990

Table 3.

The percentage of dose points calculated by the treatment planning system (TPS) with gamma (γ) values less than one when compared with those calculated by Mobius3D (M3D) for VMAT plans for cancers of the prostate, lung, and head and neck

%pointsγ5%,3mm<1
Patient # Prostate Lung Head and Neck
1 100 99.9 99.4
2 99.9 98.8 99.3
3 100 99.8 99.3
4 100 99.5 99.9
5 100 100 93.2
6 100 100 99.2
7 100 99.8 99.1
8 100 100 99.1
9 100 100 99.1
10 100 99.0 99.0
Average
100±0.0
99.7±0.1
98.7±0.6